spacer
home >
PUBLICATIONS

 
 
 
Featured in this issue

A Scalable Solution

Susan Najjar at Covance

It is important for smaller enterprises to seek specialised clinical and regulatory support in order to streamline pre- and post-marketing phases.

 


The Elephant in the Room

Kurt Mussina at Frenova Renal Research

Systematic and concrete marketing activities are an often overlooked aspect of a successful clinical research business.

 

 
Paving the Way

Rik Van Mol at Veeva Systems

In order to drive efficiency and a faster time to market, sponsors, CROs, and pharma companies need to embrace collaboration.

spacer

 

 
News and Press Releases

Pharma.Aero, the University of Antwerp, Khalifa University Abu Dhabi and HOPE Consortium launch the second international masterclass on Pharma Logistics

Following last year’s well-perceived first Masterclass on Pharma Logistics - an international joint initiative between the air cargo industry and world-renowned academic institutions – a second edition will be launched in 2022 at Khalifa University’s Abu Dhabi Campus. Apart from highlighting the current critical aspects of pharma logistics, this Masterclass aims to create a unique opportunity for industry professionals to gain more in-depth knowledge, as well as for academics and PhD students to obtain advanced insights into how pharmaceutical supply chains are organized and logistics processes are optimized through applied technology for the pharma and life science sector.
More info >>

 
White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement